 |
|
|
| |
Aesica has three state-of the-art manufacturing facilities in the UK. Between them, the three facilities spread across more than 200 acres and employ over 700 people.
Aesica offers both primary and secondary contract manufacturing services and has the facilities and expertise to develop products from the early-phase clinical stage right through to commercial supply. We provide a tailored service incorporating integrated project management and working in partnerships on all projects, from individual development and scale-up to large-scale commercial manufacturing and technical transfers. |
|
|
We currently provide contract manufacturing services for a wide variety
of APIs and Finished Dosage forms including:
• Anti-Infectives
• Cardiovasculars
• Anti-virals |
• Anaesthetics
• Anti-inflammatories
• Haematinics |
• Anti-depressants
• Hormones
• Potent drugs |
Our world-class development and manufacturing facilities comprise:
| • |
Fully equipped process development labs |
| • |
cGMP scale-up facilities |
| • |
Pilot plant for early phase process development |
| • |
7 cGMP computer-controlled multi-product plants for commercial scale API manufacturing |
| • |
Formulation manufacturing facilities |
| • |
Packaging services |
| • |
A full range of facilities for the manufacture and formulation of chemical synthetic, potent compounds and anaesthetics |
|
|
|
|
|
 |
|
 |